Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Share-based Compensation (2022 - 2026)

Tevogen's (TVGN) quarterly Share-based Compensation came in at $2.8 million in Q1 2026, down 60.93% on a YoY basis from $7.3 million in Q1 2025, and up 16.5% quarter-over-quarter from $2.4 million in Q4 2025.

Analysis

Tevogen (TVGN) Share-based Compensation (2022 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Share-based Compensation for 5 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 60.93% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (down 51.47% YoY), and the FY2025 full-year result was $83.9 million, up 105.7% from the prior year.
  • Share-based Compensation climbed to $2.8 million in Q1 2026 per TVGN's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $86.1 million in Q3 2025 and bottomed at -$302399.0 in Q4 2023.
  • Historically, Share-based Compensation has averaged $17.7 million across 5 years, with a median of $8.6 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Share-based Compensation sank 103.06% in 2023, then surged 123475.42% in 2024.
  • Over 5 years, Share-based Compensation stood at $9.9 million in 2022, then tumbled by 103.06% to -$302399.0 in 2023, then soared by 2401.93% to $7.0 million in 2024, then sank by 64.86% to $2.4 million in 2025, then rose by 16.5% to $2.8 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $2.8 million, $2.4 million, and $86.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 14.16 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 17.32 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 17.57 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 17.40 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 40.78 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 90.90 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 3.58 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 28.03 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 9.08 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.85 Mn
Dec 31, 2025 2.45 Mn
Sep 30, 2025 86.09 Mn
Jun 30, 2025 31.08 Mn
Mar 31, 2025 7.29 Mn
Dec 31, 2024 6.96 Mn
Sep 30, 2024 20.23 Mn
Jun 30, 2024 19.35 Mn
Mar 31, 2024 26.33 Mn
Dec 31, 2023 -302,399.00
Mar 31, 2023 -21,344.00
Dec 31, 2022 9.89 Mn